Cancer Core Europe provides a great translational platform to bridge the gap from bench-to-bedside and bedside-to-bench, conducting next-generation clinical trials, and discovery of predictive biomarkers and markers to monitor resistance.Read More
“The development of Cancer Core Europe is exciting. The understanding of the science that drives cancer growth is leading to rapid and significant changes in how we need to approach the diagnosis, monitoring and treatment of patients with cancer. If we are to be successful in bringing revolutionary new treatment regimens to patients quickly it will require this kind of collaboration across cancer centres. AZ Oncology looks forward to also collaborating with Cancer Core Europe to help deliver this revolutionary vision."
Susan Galbraith, Head of Oncology, Astra ZenecaRead More